Aggregate notional amount specified by the derivative(s). Expressed as an absolute value.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Article 12

-Section 13

-Sentence Column B

+ Details

Name:	invest_DerivativeNotionalAmount
Namespace Prefix:	invest_
Data Type:	xbrli:monetaryItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of common stock shares subscriptions.

+ References

No definition available.

+ Details

Name:	ofix_NumberOfCommonStockSharesSubscriptions
Namespace Prefix:	ofix_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Warrants Exercisable Period

+ References

No definition available.

+ Details

Name:	ofix_WarrantsExercisablePeriod
Namespace Prefix:	ofix_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

Exercise price per share or per unit of warrants or rights outstanding.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(i)(4))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

+ Details

Name:	us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix:	us-gaap_
Data Type:	num:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Monetary value of common stock allocated to investors to buy shares of a new issue of common stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 30

-Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 45

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6403732&loc=d3e21300-112643

+ Details

Name:	us-gaap_CommonStockSharesSubscriptions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Fixed interest rate related to the interest rate derivative.

+ References

No definition available.

+ Details

Name:	us-gaap_DerivativeFixedInterestRate
Namespace Prefix:	us-gaap_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

Date the derivative contract matures, in CCYY-MM-DD format.

+ References

No definition available.

+ Details

Name:	us-gaap_DerivativeMaturityDates
Namespace Prefix:	us-gaap_
Data Type:	xbrli:dateItemType
Balance Type:	na
Period Type:	duration

- Details

Name:	us-gaap_DerivativesFairValueLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Investing Activities

-URI http://asc.fasb.org/extlink&oid=6516133

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 230

-SubTopic 10

-Section 45

-Paragraph 13

-Subparagraph (a)

-URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentsToAcquireNotesReceivable
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

Derivative Instruments - Additional Information (Detail) Share data in Thousands, except Per Share data, unless otherwise specified	9 Months Ended				9 Months Ended
	Sep. 30, 2014 Bone Biologics Inc [Member] USD ($)	Sep. 30, 2013 Bone Biologics Inc [Member] USD ($)	Jul. 01, 2014 Bone Biologics Inc [Member] USD ($)	Dec. 31, 2013 Bone Biologics Inc [Member] USD ($)	Sep. 30, 2014 Swap Agreement [Member]	Sep. 30, 2010 Cross-Currency Swap [Member] Designated as Hedging Instrument [Member] Pay Euros [Member] EUR (€)	Sep. 30, 2010 Cross-Currency Swap [Member] Designated as Hedging Instrument [Member] Receive U.S. dollars [Member] USD ($)
Derivatives, Fair Value [Line Items]
Notional amount						€ 28,700,000	$ 39,000,000
Fixed rate (as a percent)						5.00%	4.635%
Swap agreement expiration date					Dec. 30, 2016
Purchase of note receivable	750,000	750,000
Shares purchased, value	$ 1,250,000		$ 500,000
Shares purchased, shares	458		500	125
Exercise price of warrants per share	$ 1.36			$ 1.00
Warrant exercisable period	7 years